Europe — EMA

Oncaspar (Pegaspargase)

Pegaspargase, the active ingredient in Oncaspar, is an enzyme‑based therapy presented as a sterile powder for intravenous infusion use.

Pegaspargase

Request sourcing

Pack/s

What is Pegaspargase?

Pegaspargase, the active ingredient in Oncaspar, is an enzyme‑based therapy presented as a sterile powder for intravenous infusion use. It is employed in the treatment of certain blood‑cancer related conditions, particularly in pediatric and young adult patients. GNH USA supplies Oncaspar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

GNH USA supplies Oncaspar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

What is Pegaspargase used for?

Oncaspar is ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

- ... ... ?? ... ... ... ... ... ... .... ... ... ... ... ... ... ... ... ... ... ... - ... ... ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →